PMC:7195088 / 18093-18248 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"662","span":{"begin":52,"end":60},"obj":"Species"},{"id":"760","span":{"begin":29,"end":38},"obj":"Chemical"},{"id":"923","span":{"begin":66,"end":74},"obj":"Disease"}],"attributes":[{"id":"A662","pred":"tao:has_database_id","subj":"662","obj":"Tax:9606"},{"id":"A923","pred":"tao:has_database_id","subj":"923","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"inhaled interferon alfa plus xiyanping injection in patients with COVID-19. Open-label RCT (NCT04275388, not yet recruiting). Primary endpoint: clinical re"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T89","span":{"begin":66,"end":74},"obj":"Disease"}],"attributes":[{"id":"A89","pred":"mondo_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"inhaled interferon alfa plus xiyanping injection in patients with COVID-19. Open-label RCT (NCT04275388, not yet recruiting). Primary endpoint: clinical re"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T93","span":{"begin":81,"end":86},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"inhaled interferon alfa plus xiyanping injection in patients with COVID-19. Open-label RCT (NCT04275388, not yet recruiting). Primary endpoint: clinical re"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T150","span":{"begin":8,"end":18},"obj":"Chemical"},{"id":"T151","span":{"begin":81,"end":86},"obj":"Chemical"}],"attributes":[{"id":"A150","pred":"chebi_id","subj":"T150","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A151","pred":"chebi_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"}],"text":"inhaled interferon alfa plus xiyanping injection in patients with COVID-19. Open-label RCT (NCT04275388, not yet recruiting). Primary endpoint: clinical re"}

{"project":"LitCovid-sentences","denotations":[{"id":"T121","span":{"begin":76,"end":125},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"inhaled interferon alfa plus xiyanping injection in patients with COVID-19. Open-label RCT (NCT04275388, not yet recruiting). Primary endpoint: clinical re"}